EGLN2 and neoplasm: Functional studies showed that inhibition of PHD1-mediated Beclin1 P54 hydroxylation and autophagy by Beclin1 P54A knock-in expression or an autophagy inhibitor in combination with a HIF2α inhibitor treatment exhibited much-improved tumor growth inhibition compared to abrogation of autophagy or HIF2α alone.